Q1/22 Results
Babylon Delivers Massive Growth and Adjusted EBITDA Margin Improvement in the First Quarter of 2022 and Raises 2022 Revenue Guidance
First quarter 2022 revenue grew over 3.5x year-over-year to $266 million
Increasing 2022 guidance for revenue to $1.0 billion or greater and updating
Adjusted EBITDA Margin of (27)% for the quarter, ahead of previous full-year 2022 guidance of (30)%
U.S. value-based care members grew by 63% from Q4 2021 to a total of more than 270,000 members